• Oteseconazole (VT-1161): Applied Antifungal Workflows & Trou

  2026-05-19

  Oteseconazole (VT-1161) redefines antifungal research with robust selectivity against Candida species, including fluconazole-resistant strains. This guide delivers practical protocols, advanced applications, and troubleshooting strategies to help researchers maximize the value of this next-generation antifungal agent.

• Machine Learning Predicts Lipid Nanoparticles for mRNA Vacci

  2026-05-19

  This study presents a machine learning approach for predicting efficient lipid nanoparticle (LNP) formulations for mRNA vaccine delivery, identifying critical ionizable lipid substructures and validating key predictions experimentally. The findings offer a computational alternative to labor-intensive lipid screening and provide mechanistic insight into mRNA–LNP interactions.

• Cell Surface Integrity Sets Ploidy Limits in Budding Yeast

  2026-05-18

  This study establishes that the maximal ploidy in Saccharomyces cerevisiae is constrained by cell surface integrity rather than by intrinsic genomic or cell cycle limitations. By experimentally generating high-ploidy yeast, the authors show that alleviating cell surface stress extends ploidy tolerance, revealing new intersections between genome content, membrane biology, and cellular physiology.

• Inhibition of Renal OCT2/MATE1 by 5-HT3 Antagonists: Tropise

  2026-05-18

  This study systematically evaluates how various 5-HT3 receptor antagonist antiemetic drugs—including tropisetron—can inhibit renal secretion by targeting organic cation transporters OCT2 and MATE1. The findings provide important mechanistic data on drug-drug interaction risks and inform experimental design for neuroscience and pharmacology research.

• Tropisetron Hydrochloride: Advancing 5-HT3 Antagonist Resear

  2026-05-17

  This thought-leadership article explores the mechanistic role of Tropisetron Hydrochloride as a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist, examining its translational potential in neuroscience and renal transporter research. Drawing on recent comparative studies and established APExBIO quality, the article provides actionable guidance for protocol optimization, mechanistic insight into serotonin receptor signaling, and a realistic assessment of future opportunities and limitations.

• Reserpine (N1867): Technical Guide for Neuropharmacology Lab

  2026-05-16

  Reserpine (SKU N1867) is a high-purity, well-characterized reagent designed for rigorous neurotransmitter depletion and antihypertensive mechanism studies in neuropharmacology research. It is not suitable for clinical, diagnostic, or long-term solution applications, and must be handled using strict workflow protocols to ensure consistency and compound integrity.

• (-)-Epigallocatechin Gallate: Applied Protocols and Assay So

  2026-05-15

  (-)-Epigallocatechin gallate (EGCG) from APExBIO empowers high-precision apoptosis, antiangiogenic, and antiviral workflows. This guide translates advanced research findings into actionable protocols, troubleshooting tips, and cross-domain applications for maximizing EGCG's experimental and translational impact.

• PINK1/Park2-Mediated Mitophagy as a Therapeutic Target in NA

  2026-05-15

  This study uncovers the protective role of PINK1/Park2-mediated mitophagy in alleviating non-alcoholic fatty liver disease (NAFLD) by modulating mitochondrial quality and reducing lipid accumulation and inflammation. The work highlights mitophagy as a promising mechanistic and therapeutic avenue for NAFLD intervention.

• BIBR 1532 Telomerase Inhibitor: Workflows & Troubleshooting

  2026-05-14

  BIBR 1532, a selective telomerase inhibitor from APExBIO, empowers researchers to dissect telomerase-driven cancer pathways with precision. This guide translates recent translational findings and protocol enhancements into actionable workflows, troubleshooting advice, and advanced applications for reliable, reproducible results.

• 5-HT3 Antagonists Inhibit Renal OCT2 and MATE1: In Vitro Evi

  2026-05-14

  This study systematically investigates the inhibitory effects of antiemetic 5-HT3 receptor antagonists, including tropisetron, on renal organic cation transporters OCT2 and MATE1. The findings highlight the potential for clinically relevant drug-drug interactions mediated by these transporters and provide actionable data for further research in transporter pharmacology and serotonin receptor signaling.

• Aprotinin (BPTI): Reproducible Solutions for Cell Assays

  2026-05-13

  This article delivers an evidence-based exploration of Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI), SKU A2574, as a cornerstone reagent for cell viability and cytotoxicity workflows. We address real laboratory scenarios, compare vendor reliability, and provide actionable protocol guidance—empowering biomedical researchers to optimize assay reproducibility and data quality.

• PD0325901 MEK Inhibitor: Optimizing Cancer Pathway Assays

  2026-05-13

  PD0325901 empowers high-precision RAS/RAF/MEK/ERK signaling pathway inhibition for dissecting cancer cell behaviors and tumor suppression mechanisms. This workflow-centric guide details experimental setups, troubleshooting, and the latest integration of telomerase regulation insights—enabling rigorous, reproducible assays for oncology research.

• PEI-Modified Laminarin Nanoparticles as Potent Vaccine Adjuv

  2026-05-12

  This study introduces cationic laminarin nanoparticles, modified with polyethyleneimine (PEI), as an innovative vaccine adjuvant platform for enhancing antigen-specific immune responses. The work demonstrates improved antigen uptake, dendritic cell activation, and robust humoral and cellular immunity compared to conventional adjuvants, highlighting the potential of functionalized polysaccharide carriers in next-generation nanovaccines.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-05-12

  This article examines a recent study demonstrating that tumor microenvironment-responsive nanoparticles can deliver PTEN mRNA to effectively reverse trastuzumab resistance in HER2-positive breast cancer. The approach restores PTEN expression, suppresses PI3K/Akt signaling, and offers a promising platform for overcoming major therapeutic challenges in cancer treatment.

• Nelfinavir Mesylate: Applied Workflows for HIV-1 Protease In

  2026-05-11

  Nelfinavir Mesylate’s dual role as a potent HIV-1 protease inhibitor and a modulator of ferroptosis makes it indispensable for advanced virology and cell death research. This article translates the latest bench findings and protocol enhancements into actionable guidance for maximizing reproducibility and data depth with APExBIO’s Nelfinavir Mesylate.

406 records 8/28 page Previous Next First page 上5页 678910 下5页 Last page